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The Ethics of Synthetic Biology: Outlining the Agenda
Abstract
The projects and aims of synthetic biology raise various ethical questions, challenging some of our basic
moral concepts. This chapter addresses these issues in three steps. First, we present an overview of
different types of ethical issues related to synthetic biology by assigning them to three main categories:
method-related, application-related, and distribution-related issues. The first category concerns the
procedure and aims of synthetic biology, the second deals with certain planned applications of synthetic
biology and the third with questions of distribution and access to procedures and products of this
technology. Next, we address a statement often raised in the discussion about ethics of synthetic
biology, namely that the ethical issues of synthetic biology have been discussed in previous debates and
therefore do not need to be addressed again. We argue that past debates do not render the discussion of
ethical issues superfluous because synthetic biology sets these issues in a new context and because the
discussion of such issues fulfills in itself an important function, namely by stimulating thought about our
relationship to technology and nature. Furthermore, given that synthetic biology's aims go beyond those
of previous technologies, we suggest that it does in fact raise novel ethical issues. Finally, we present
opinions of European synthetic biologists on ethical issues in their field. At such an early stage of
technological development, synthetic biologists play an important role in the assessment of their
discipline, and are best placed to estimate the scientific potential of the field. In an attempt to capture the
intuitions of the European synthetic biology community, we have carried out interviews, the results of
which we briefly summarize in this last section. By presenting an overview of the various ethical issues
and their actual and perceived importance, this chapter aims at providing a first outline for the agenda
for an ethics of synthetic biology.
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The Ethics of Synthetic Biology: Outlining the Agenda 
Anna Deplazes, Agomoni Ganguli-Mitra, Nikola Biller-Andorno 
Abstract 
The projects and aims of synthetic biology raise various ethical questions, 
challenging some of our basic moral concepts. This chapter addresses these issues in 
three steps.  
Firstly, we present an overview of different types of ethical issues related to 
synthetic biology by assigning them to three main categories: method-related, 
application-related, and distribution-related issues. The first category concerns the 
procedure and aims of synthetic biology, the second deals with certain planned 
applications of synthetic biology and the third with questions of distribution and 
access to procedures and products of this technology.  
Next, we address a statement that is often raised in the discussion about 
ethics of synthetic biology, namely that the ethical issues of synthetic biology have 
been discussed in previous debates and therefore do not need to be addressed again. 
We argue that preceding debates do not render the discussion of ethical issues 
superfluous because synthetic biology sets these issues in a new context and because 
the discussion of such issues fulfills in itself an important function by stimulating 
thought about our relationship to technology and nature. Furthermore, given that 
synthetic biology’s aims go beyond those of previous technologies, it does in fact  
raise novel ethical issues. 
Finally, we present opinions of European synthetic biologists on ethical issues 
in their field. At such an early stage of technological development, synthetic 
biologists play an important role in the assessment of their discipline, and are best 
placed to estimate the scientific potential of the field. In an attempt to capture the 
intuitions of the European synthetic biology community, we have carried out 
interviews, the results of which we briefly summarize in the last section. 
By presenting an overview of the various ethical issues in synthetic biology and their 
actual and perceived importance, this chapter aims at providing a first outline for 
the agenda for an ethics of synthetic biology. 
 2 
Introduction: 
Synthetic biologists aim at revolutionizing biotechnology, promising new benefits and 
the addition of new levels of comfort to modern society. However, this technology is also 
bringing with it potential for various associated risks and dangers. Its main objective 
involves the control, design and synthesis of living organisms, a goal that affects, among 
others, two delicate societal concepts: ‘nature’ and ‘life’. By disassociating these two 
notions more vigorously than any previous technology, synthetic biology challenges 
some of our deeply held values and intuitions on this topic. Similarly to other 
biotechnologies, its science and application also have various other impacts on society, 
raising a spectrum of ethical concerns. 
1. Three types of ethical issues associated with synthetic 
biology 
The emergence of a novel technology such as synthetic biology raises different kinds of 
ethical issues. In order to organize the discussion of these questions we have divided 
them into three categories: method-related, application-related, and distribution-related 
issues. The first category deals with the aims, procedures and methodologies of synthetic 
biology. The second category concerns the social impact that certain applications and 
products of synthetic biology may have in the future and the third category comprises 
questions of access and ownership. Application- and distribution-related issues can 
largely overlap between various coexistent emerging technologies. The ethical issues 
most specific and exclusive to a technology are usually those related to its specific aims 
and methodology. In the case of synthetic biology, one of the most interesting questions 
deals with the concept of living entities and the normative consequences that may follow 
from it. Comparison to previous and parallel ethical discussions are a chance to improve 
the ethical assessment of synthetic biology, but reference to them cannot replace the 
current discussion, since certain concerns retain their relevance over time and across 
different fields. The categorization into method-, distribution- and application- related 
ethical questions can be useful to compare issues and existing debates in different 
technologies. There are, of course, overlaps between the categories: the distribution of a 
synthetic biology product will generally be closely related to its specific application and 
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moral questions concerning life and living organisms will also be largely informed by the 
discussion regarding applications.  
1.1. Method-related questions 
Because it is a very heterogeneous field we cannot talk of the method in synthetic 
biology. Procedures as different as DNA-synthesis, metabolic engineering, chemical 
synthesis of protocells, computer modeling or synthesis of alternative nucleobases all are 
part of synthetic biology [1]. Whereas there are some technological overlaps between 
certain forms of synthetic biology with traditional biotechnology and chemistry the 
specific aspect of synthetic biology is its objective, which is also what in one way or 
another is shared by all approaches. Synthetic biology aims at creating or designing new 
forms of life, following a human ‘architecture’ and plan. This aim per se raises certain 
ethical questions related to the relationship between humans and other living organisms 
and the moral status of the products of synthetic biology.  
Artificial organisms 
So far, living organisms have essentially been products of nature, even when they have 
been modified by breeding or genetic engineering, their overall body plan and 
metabolism still follows the natural design resulting from evolution. The idea that 
humans can synthesize life following their own design establishes a new concept of life. 
The difference between living organisms and machines becomes more transient, given 
that machines are often characterized by an existence for specific purposes dependent on 
human design. These machine-like features would also be true for an artificial cell as it is 
aspired by some synthetic biologists [2, 3]. However, human beings can typically control 
classical machines during their entire existence and machines can arbitrarily be switched 
on and off, which would not necessarily be the case for an artificial cell. Such a cell thus 
has some but not all the features of a machine. On the other hand the ultimate artificial 
cell should be autopoietic, meaning that it would be able of self-organisation and self-
production, which would be a classical feature of living organisms [4]. It therefore 
remains unclear, whether such cells can be considered ‘alive’.  
Positions arguing that living organisms have intrinsic value are confronted with the 
question about the moral status of artificial organisms and the responsibility that the 
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‘creator’ would have towards it. However, we should be aware of the fact, that to date, 
scientists are far from being able to build a real artificial cell, not to mention multicellular 
organisms, therefore such settings should rather serve as philosophical thought-
experiments, than as a basis to regulate synthetic biology. 
Living machines 
The bioengineering branch of synthetic biology aims at making biology an engineering 
discipline by systematizing genetic engineering, based on standardized parts at the DNA 
level, which can be combined into modules, which again can be combined into metabolic 
pathways [5, 6]. In this context some synthetic biologists call their products ‘Genetically 
Engineered Machines’ as illustrated by the title of the annual SB-competition : iGEM 
(The international Genetically Engineered Machine competition 
http://parts2.mit.edu/wiki/index.php/Main_Page ). The analogy to machines is based on 
the previously mentioned inherent purpose as well as human design and control, which 
are characteristic for machines. A genetically engineered machine would be a living 
machine, an interesting entity raising the questions whether it is possible to turn living 
organisms into machines whether there is any fundamental difference between living 
organisms and machines and if so, what such a distinction would be based on and 
whether it could be lost. This leads to the question whether taking the attribute ‘living’ 
from any organism would change its moral status. The answer to this question depends 
on the attitude towards nature and living organisms and probably cannot be answered 
definitively. However, it is clear that in this context synthetic biology raises interesting 
questions with a potentially high social impact. 
1.2. Application-related questions 
At such an early stage of a technology, we can at best speculate about the potential 
impacts of its future applications. This incertitude implies, on the one hand the risk of 
discussions about exaggerated hopes as well as about unnecessarily bleak scenarios. On 
the other hand an early start offers the opportunity to accompany and influence the 
development of the technology and to avoid the often encountered scenario where ethical 
assessment lags well behind technological development. In the following we address 
three different fields of applications that could raise ethical questions: 
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Release of synthetic organisms into the environment for bioremediation 
One goal of synthetic biologists is the synthesis of microorganisms that could identify 
contaminated areas or that could degrade pollutants in the environment [7]. However, 
beyond the obvious advantages of such a system, some problems need to be considered. 
In order to clean up polluted areas, microorganisms must be released into the 
environment. Since synthetic organisms, unlike synthetic chemicals can reproduce and 
evolve, there is a certain danger that after the degradation of the pollutant the 
microorganisms might persist, interact with, affect or displace endogenous species. The 
ethical question in this context concerns our dealing with the environment; it is not clear 
to what extent we are permitted to expose nature to such a risk and whether we have the 
right to interfere with the composition of the ecosystem in such a direct way. On the other 
hand, it can also be argued that the degradation of pollutants is not only an advantage for 
humans but also for all other organisms and the environment, leading to a tradeoff 
between risks and benefits for nature and society.  
 
Synthesis of pathogenic viruses or microorganisms 
It has been shown that de novo DNA synthesis can be used to produce pathogenic viruses 
[8]. Given that the synthesis of DNA is ever becoming cheaper this possibility 
enormously facilitates the access to such pathogens. Furthermore, it is possible that novel 
types of infective viruses could be designed and produced. This is a serious biosafety and 
biosecurity issue that has been addressed in detail [9, 10, 11]. It is perhaps safe to 
imagine that all stakeholders would agree on the need of regulation to prevent misuse.  
The question is how far this regulation should go. At which point is it discriminatory to 
control members of certain countries more rigorously than others on whether they are 
using ordered DNA sequences for permissible purposes? At what point is freedom of 
research compromised, when scientists are not allowed to build certain viruses or order 
certain DNA sequences? To what point can such a tightly controlled DNA synthesis 
system lead to an unjust monopoly of certain companies? Is the power that is connected 
to this regulation at the right ‘place’, is it distributed justly? Given that these issues have 
to be balanced against the safety and security of human individuals and populations, there 
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are strong ethical arguments in favor of tight regulation of DNA-synthesis but attention 
needs to be paid to making this regulation just and fair also from a research perspective. 
Synthetic biology in mammalian cells 
Originally, synthetic biologists designed artificial pathways for bacteria and unicellular 
eukaryotes such as yeast. But this technology is increasingly also applied in human cells 
[12], which might for example enable novel applications in gene therapy. This 
development of the technology can raise ethical question, particularly if it is applied in 
human embryonic stem cells [13]. Theoretically, such stem cells could be used for 
reproductive technologies. These procedures could be ethically even more problematic 
than the hitherto discussed selection of favored embryos among several ‘natural’ embryos 
because on this track synthetic biology could lead into extreme forms of human 
enhancement. However, to the authors’ knowledge such applications are currently not 
seriously intended and it would not be reasonable to base an ethical assessment too much 
on such futuristic applications. Nevertheless, it is necessary to keep such scenarios in 
mind and observe the application of synthetic biology in human embryonic stem cells 
critically. 
3. Distribution-related questions 
Each new technology, especially one dealing with living organisms, brings with it risks 
as well as benefits. It is ethically relevant to address the distribution of these positive and 
negative consequences as well as the access to the technology and its products 
Regulation of intellectual property   
The access to biotechnological products is generally regulated by patents, which should 
protect the creative work of authors and stimulate progress in science and technology 
[14]. For the latter purpose patents should promote the access to scientific information by 
making it public. However, by conferring monopolies on certain information, or in cases 
of extensive patenting (as e.g. in case of gene patents) patents can restrict accessibility to 
important inventions and discoveries [15]. Furthermore, patents in traditional 
biotechnology have raised ethical concerns because products affect vital sectors such as 
nutrition and medicine [16]. Synthetic biology might tighten this situation. Furthermore, 
the patent situation is complicated by the involvement of many different disciplines 
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(biology, chemistry, computer sciences, engineering), which means that researchers may 
be restricted by patents from different sides. This is particularly problematic because 
there is a tendency to patent not only final products but also basic techniques and ideas 
[17]. However, e.g. the BioBrick foundation provides a large collection of standardized 
biological parts for bioengineering, which is available to the public free of charge 
(http://bbf.openwetware.org/). Such a ‘distribution strategy’ reminding of the open 
software model is an interesting alternative to a very tight patenting system as found in 
traditional biotechnology. However, at the level of commercialized applications and 
products, a tighter regulation of access might economically be required. The question of 
IP regulation in synthetic biology requires further analysis and discussion, not only from 
economical or legal but also from a societal and ethical point of view. 
Global divide 
Another concern raised by the distribution of synthetic biology is that of the global access 
to its products and the scientific knowledge accruing from the research. Will synthetic 
biology significantly contribute to widening the economic and infrastructural gap 
between industrialized nations and developing countries? On the one hand, it has been 
argued that the development of synthetic biology products might replace less efficient 
procedures of producing the same or comparable products by traditional methods in the 
developing world as e.g. in case of the malaria drug artemisinin [18]. On the other hand, 
we are dealing with the problem that developing countries might not have access to 
products of synthetic biology. This issue is particularly relevant for biotechnology in 
general and synthetic biology in particular, because synthetic biology products such as 
medicines and therapies, bioremediation products or renewable and cheap energy sources 
might help to solve some of the problems that particularly plague these countries. The 
synthesis of such products by living organism can be expected to be more cost-effective 
than chemical synthesis. Therefore, such an application could indeed become an 
important developmental tool for poorer countries. However, research and development 
in synthetic biology requires the usual cost-intensive biotechnological equipments, and 
scientific knowledge and training, which, so far, have mainly been clustered in 
prosperous nations. If no effort is given to enhancing the scientific and technological 
infrastructure of developing nations along with the development of such application, 
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synthetic biology may only serve to reinforce the dependency of poor nations on rich 
nations. Similar problems, alternatively known as the ‘digital divide’ or ‘nano divide’ are 
being addressed by commentators in information and communication technology or 
nanotechnology [19, 20]. The synthetic biology community, if committed to preventing a 
global synthetic biology-divide, can certainly profit from this work, and contribute 
towards addressing a problem that is still far from being solved.  
2. Addressing the ethical issues in synthetic biology 
In the previous section, we have listed a set of potential ethical issues that may be raised 
by synthetic biology. Next, we would like to address the question of how to deal with 
such concerns.  
It would be wrong to expect that ethical issues can easily be solved and to everybody’s 
satisfaction. The conclusions of different ethical theories, religious convictions or other 
norms sometimes may be in agreement with each other concerning an ethical issue, 
however, often, opinions differ substantially, even if each theory is fully consistent in 
itself.  
An interesting approach that allows considering different ethical theories as well as 
concrete moral judgments, is the wide reflective equilibrium. In order to arrive at a wide 
reflective equilibrium we need to work back and forth among our moral judgment and 
intuitions, principles and rules and also the theoretical considerations that we are 
supporting. The aim is to arrive at acceptable coherence among these beliefs by revising 
our moral judgments, principles and the background theories until they ‘fit together’. This 
method of justification allows representatives from different positions to develop their 
judgment regarding one particular case taking ideas of other positions into consideration. 
This notion that moral judgments and theories are revisable facilitates representatives of 
different positions to arrive at a similar conclusion although each of them justifies it in 
light of its own beliefs and theory [21].  
The process of looking for moral judgments that can be shared by different positions is an 
important process that asks for the interaction of the different parties as it takes place in a 
multi-stakeholder approach for technology assessment. The discussions among the 
stakeholders should not be considered merely as a means to an end, but they may 
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themselves be one of the most important aspects of the ethical assessment. They allow 
society and the different stakeholders to deal with difficult problems that affect deeply 
held values and beliefs. Ideally, they offer a platform allowing a solid reflection on other 
opinions as well as adjustment of one’s own position. Misunderstandings and conflicts, 
which are sometimes simply based on disagreement in assumptions or premises, can be 
conferred.  
2.1. These ethical issues have been discussed before 
Some commentators claim that synthetic biology does not present any novel ethical issue. 
They say that our society is already living with various technologies and that 
technologies such as genetic engineering are already interfering with the ‘natural state’ of 
living organisms, in other words, they seem to imply that the similarity to previous 
technologies renders the discussion of ethical issues in synthetic biology superfluous 
[22]. However, even if these commentators were right in saying that synthetic biology 
does not raise any fundamentally novel ethical issues, it would still be sensible to 
encourage a discussion for at least three reasons. First, if we act on the assumption that 
positions or arguments may change over time, new circumstances may lead to a different 
assessment of the same arguments. History has shown that moral opinions can change. 
Second, while the theoretical debate takes place at a somewhat abstract level, actual 
ethical decisions are often heavily influenced by existing societal contexts. Ethical 
priorities may vary not only according to values and preferences but also according to 
needs. What may be optional or palliative in one context may be seen as obligatory or 
impermissible in another context. Third, as mentioned above, the purpose of ethical 
discussion is not solely to find solutions but the process of discussing is required to deal 
with difficult issues and refine positions. Questions about the value of nature and our role 
in it will probably (and hopefully) engage many future generations and will most likely 
not be answered once and for all.  
Additional motivation for an ethical assessment of synthetic biology comes from ethical 
questions, which are indeed novel. As mentioned in the first section of this chapter such 
questions are particularly raised by the new approach and more extreme techniques of 
synthetic biology. Whereas in the domestication and breeding of animals or in genetic 
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engineering the intended alterations of an organism were based on specific traits or genes, 
synthetic biology starts from an integral approach with the aim to create something 
fundamentally new. Its goal far exceeds that of traditional biotechnology. Synthetic 
biologists not only want to adapt living organisms to human purposes, they aim at 
producing living machines or completely artificial organisms, depending on the approach. 
Therefore the extent of ‘technologization’ of the living world caused by synthetic biology 
will be larger and more systematic. The creativity of human beings is entering a new 
domain, and the differences between living and non-living are getting further blurred. 
Therefore, the scientific characteristics, which, according to experts make synthetic 
biology a novel discipline, distinct from traditional biotechnology, are also those that 
pose novel ethical challenges.  
2.2. The role of society in the ethical discussion 
Any technology justifies its necessity and importance by pointing at its potential benefits 
for society. However, society is also deeply involved in different ethical concerns related 
to synthetic biology. For example the question of acceptable risks versus promised 
benefits or a challenge to the fundamental concepts anchored in culture and religion such 
as the concept of life should not be contained within academic debates. Opinions of the 
public, often reflecting some of our deeply held values, feed the academic or policy 
debate and are a crucial ingredient to a successful assessment of the technology. In case 
of a novel technology such as synthetic biology the public can only form a well-founded 
opinion, if it has certain knowledge about the technology. However, for laypersons it is 
generally difficult to access this information including professional predictions about 
potential consequences and side effects that are not entirely known to experts themselves. 
It is thus essential and it is a right of society to receive as much information about novel 
technologies as possible in order to be able to form an informed opinion. The GMO 
(genetically modified organisms) debate in Europe has shown impressively that the 
societal acceptance of a technology is not only ethically but also economically desirable 
[16] this should add to the motivation to keep the public informed. 
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2.3. The role of synthetic biologists in the ethical discussion 
Synthetic biologists are of course part of society, but more than anybody else they should 
be able to ‘foresee the unpredictable’. However, they are undeniably biased in favor of 
their research, which implies the risk that problematic aspects may sometimes 
consciously but most of the time unconsciously be denied or overlooked against better 
judgment. There are thus at least two important reasons for involving synthetic biologists 
in the ethical discussion. On the one hand, they can provide other stakeholders with 
valuable scientific knowledge; on the other hand, the other parties can present various 
ethical concerns and dangers to the scientists. Both sides can therefore profit from such a 
dialog.  
As a matter of fact, synthetic biologists are encouraging the dialog between different 
stakeholders. Social scientists and ethicists do have sessions at scientific synthetic 
biology conferences and assessment of synthetic biology is supported by scientific boards 
[9]. The framework for the discussion has been established; it is now a question of 
individual interest and participation on both sides, which will decide about the success of 
the interaction. 
3. The opinion of synthetic biologists on ethical issues 
concerning their discipline 
 
In order to understand the attitude of synthetic biologists on ethical issues in synthetic 
biology we performed interviews with 20 synthetic biologists participating in the NEST 
(New and Emerging Science and Technology) pathfinder initiative: Synthetic Biology, 
which is supported by the 6th framework program of the European Union [23]. In what 
follows, we briefly summarize the main topics, which came across in these discussions.  
No specific ethical issues exist at the moment 
In line with the opinions stated earlier, many scientists felt that synthetic biology did not 
pose any ethical issues, or, at least not any new ones. In the words of one of the 
respondents, creating artificial entities or working within the synthetic world is “part of 
what man does”, given that the nature of human beings is to “escape the natural”. Some 
respondents recognized that the ethical issues might be the same as those in science in 
general, but that synthetic biology posed not additional issue as such, or that the ethical 
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issues were the same as in traditional genetic engineering but more relevant or stronger, 
given the increased precision and efficiency of current methods and technology. Others 
still, felt that although future applications may pose ethical problems, synthetic biology at 
this stage (typically the single-cell manipulation stage) did not raise special issues. 
Finally, one respondent felt that synthetic biology might pose, at best, some interesting 
philosophical and metaphysical but no ethical questions as such. This last comment 
seemed to point towards questions related to nature and life. However, the normative 
implications of such questions do not seem to particularly concern scientists. 
Ethical issues are related to safety and security 
For those respondents who did think that there were ethical issues related to synthetic 
biology, almost all felt that these were mainly related to safety and security issues, at 
least in the short term. One respondent, echoing the concerns raised by the synthetic 
biology community in the US, emphasized that the ethical issues were related to the 
availability, with the advent of synthetic biology, of “cassette-like biological systems and 
the additional information on the internet, which may allow the easy production of 
dangerous and even lethal biological constructs and associated delivery systems”.  
Coupled with biosecurity worries were those related to biosafety. Respondents warned of 
the lack of knowledge regarding how synthetic organism may behave in nature: “it is ok 
as long as it is in the lab…not sure how it will interact once out!” On the other hand, one 
scientist explained that the “uncontrollability” fears stemmed from not knowing how 
natural organism react and interact, and that synthetic biology with its quest for higher 
controllability, was somehow the “answer to all these fears”.   
Ethical issues are related to the application and distribution of synthetic biology 
According to a few respondents, the main ethical issues in synthetic biology are related to 
applications and that it is not the technology, but the applications that “matter”. For 
example, to some, concerns may arise if synthetic biology is applied in higher organisms, 
especially if applied to the synthesis or manipulation of human DNA; as one respondent 
put it firmly: “no application for human genome manipulation, this is the only important 
(ethical issue)”. Reflecting on the various applications of synthetic biology, one 
respondent touched upon a concern that might be interpreted, the light of a response to a 
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question about ethics, as one of instrumentalization: we are bringing a “wholesale change 
to the genome, creating life to do something useful” . 
At least two respondents raised the issue of commercial involvement and intellectual 
property (IP) rights. It was noted that IP rights were the product of western rich nations 
but that synthetic biology can have benefits for the whole world.  
Ethical issues are created by the public 
Although rarely explicitly expressed, there seemed to be a feeling among some 
respondents, that somehow ethical issues were related to public perception. In other 
words, ethical concerns were only what the public made them, or that ethical concerns 
regarding synthetic biology might only arise for those religious-minded.  As such, one 
respondent predicted that if “weird” things were created in the lab, they might trigger a 
strong reaction. A few scientists, echoing this thought, mentioned the problem of the 
“Frankenstein factor” which might tilt the scale of public perception against synthetic 
biology. Taking the “Frankenstein factor” further, one respondent suggested that in order 
to avoid a strong public reaction, synthetic biology should not be said to be  “creating 
life”, but rather aimed at creating “self-replicating biological complex entities”. This 
interestingly echoed the suggestion, at the height of the cloning debate, of many 
scientists, to refer to therapeutic cloning as simply SCNT (somatic cell nuclear transfer), 
and to avoid the emotive ‘cloning’ term.  
Finally, suggesting that public participation might be of importance to the developing 
field of synthetic biology, one respondent stated: “We cannot expect to have a field with 
new life and ignore bioethical aspects. We need to avoid fundamentalism one way or 
another. Those who are opposed to it might be ignorant but should be taken into 
account”. 
The debate in synthetic biology can be compared to the GMO debate 
When respondents were asked whether they had, perhaps earlier on in their careers, faced 
similar debates regarding other biotechnologies, many drew a parallel between the GMO 
debate, perhaps more so given the history of the GMO debate in Europe and underlying 
concerns related to lobby groups and the possibly inflammatory role of the media. A 
number of the respondents were worried about a GMO-like backlash but interestingly 
scientists were divided in their conclusions of this comparison. While some felt that 
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synthetic biology might trigger stronger negative reactions because it promised more 
radical changes, others said that synthetic biology would receive a milder reaction 
because of its potential therapeutic promises. Unlike GMO, the products of synthetic 
biology might be seen to be important in the development of drugs and treatments, and 
not something “you would feed to your kids”.  
Ethical assessment concomitant with the development of synthetic biology might be 
advisable 
Among the scientists interviewed, some expressed the need for ethical enquiry in the field 
of synthetic biology but while advising a precautionary approach to development, felt 
that there were not (yet) any precise issues that needed attention. Other respondents 
advised that progress of synthetic biology should be “supervised and controlled”, or that 
there was a need for projects to be approved by ethical committees. 
Other expressed concern included the role and responsibility of scientists: “what will be 
our status: scientists? Creators?” it was further emphasized that as potential “creators” 
scientists would have the ethical responsibility to delineate what should or should not be 
created. According to another scientist, synthetic biologist had the further responsibility 
of preserving the natural habitat and preventing genetic pollution.  
Summary of the interviews 
The responses given in these interviews illustrate that there is a general awareness of 
ethical issues in synthetic biology among the interviewees and that they have heard of 
previous and similar ethical debates. Some answers indicate that scientists have already 
been thinking about these questions. This observation is in accord with the relatively 
important presence of societal topics at synthetic biology conferences and in scientific 
journals. Most probably, the ethical awareness of synthetic biologists is partially a cause 
of and partially a consequence of the fact that these questions are present in the scientific 
agenda. 
As expected, none of the interviewees considered the ethical issues raised by synthetic 
biology alarming or insurmountable. Several respondents rather thought they were 
insignificant. However, many synthetic biologists did mention one or the other ethical 
question they regarded as relevant. Among these issues were application-related, 
distribution-related as well as method-related concerns. 
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The perception of the public opinion of ethical issues is again not uniform. Some 
responses indicated that the public opinion was perceived as threatening and 
unreasonable. However, other statements expressed understanding for public fears and 
the importance to inform people about the development of the technology. 
4. Conclusion 
Synthetic biology is a fascinating field not only for scientists and engineers involved in it 
but for anybody interested in its aims and ideas. The thought that human beings might 
soon be capable of synthesizing and controlling life evokes scenarios and utopias which 
are particularly concrete precisely because the idea of artificial life designed by human 
beings is not new but a recurrent topic in literature, film and philosophy. The euphoria 
and creativity with which the idea of synthetic biology is presented e.g. by the annual 
students competition iGEM mentioned before, may add to the popularization of this field.  
However, it is very important to distinguish clearly between utopias and reality and not to 
let emotions raised by the former, affect conclusions in the assessment of the other.  
Our overview of different types of ethical issues raised by synthetic biology, the analysis 
of the dealing with these issues and the presentation of scientist’s perspective on them, 
aims at addressing ‘ethics of synthetic biology’ from a neutral point of view. We have 
referred to similar ethical discussions and pointed out that it is useful and reasonable to 
draw the parallel and profit from the previous debates. However, we have also pointed 
out that these similarities do not render the ethical discussion of synthetic biology 
superfluous because the discussion stands in a new context and because synthetic biology 
does raise novel issues. Synthetic biologists are exemplary in discussing ethical issues 
and consulting and involving social scientists and ethicists at a very early stage in the 
development of this technology. The awareness of these issues and the readiness to 
participate in a dialogue provide a positive precondition for a fruitful ethical assessment 
of synthetic biology. 
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